Want to join the conversation?
Personal navigation devices maker $GRMN reported a rise in 1Q16 earnings driven by lower foreign currency losses. Net income rose to $88.09MM or $0.46 per share from $66.79MM or $0.35 per share last year. Net sales grew to $624.04MM from $585.39MM. Pro forma EPS decreased to $0.49 from $0.55.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?